Governments need to put in place policies that will address all elements related to medical devices, ranging from access to high quality, affordable products, appropriate use and disposal. The health technology life cycle illustrates the policy process that needs to…
Emergency Use Listing (EUL) procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. The EUL replaces the Emergency Use Assessment and Listing (EUAL) procedure, which was used during the West Africa Ebola outbreak of 2014-2016.
The TAG-CO-VAC considers that COVID-19 vaccines that have high impact on prevention of infection and transmission, in addition to the prevention of severe disease and death, are needed and should be developed. Until such vaccines are available, and as the SARS-CoV-2 virus evolves, the composition of current COVID-19 vaccines may need to be updated, to ensure that COVID-19 vaccines continue to provide WHO-recommended levels of protection against infection and disease by VOCs, including Omicron and future variants.
The States whose governments have been invited to send observers to the International Health Conference hold in New York, 1946, may become Members by signing or otherwise accepting this Constitution in accordance with !he provisions of Chapter XIX and in accordance with their constitutional processes provided that such signature or acceptance shall be completed before the first session of the Health Assembly.
On Wednesday, Ambassador Tai issued a statement saying the extraordinary circumstances caused by the COVID-19 pandemic required extraordinary measures to respond and that the waiving of intellectual property protections on vaccines was needed to help end the pandemic. The United States would, the statement continued, participate in World Trade Organization negotiations to support the temporary waiving of protections, and work with the private sector and other partners to expand vaccine manufacturing and distribution.
The WHO Emergency Use Listing Procedure (EUL) is a risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency. This will assist interested UN procurement agencies and Member States in determining the acceptability of using specific products, based on an essential set of available quality, safety, and efficacy and performance data.
In children, the major diseases disseminated by airborne and droplet spread are acute respiratory infections, particularly pneumonia, influenza, measles, pertussis (whooping cough), meningococcal meningitis and diphtheria, which together kill at least four million. Direct contact diseases in children include poliomyelitis and trachoma, a major cause of blindness in developing countries. Among adults, tuberculosis is the leading airborne disease, killing three million people and infecting almost nine million others every year. It is already the opportunistic infection that most frequently kills HIV-positive people: of an estimated one million AIDS-related deaths in 1995, about one-third may have been due to tuberculosis. Leprosy still affects 1.8 million people in 70 countries, but is steadily being eliminated as a public health problem. Influenza and pneumonia strike children and adults, especially the elderly.
The first World Health Assembly, held in June 1948 and attended by 53 delegates from WHO's 55 Member States, approved a programme of work that listed its top priorities as malaria, maternal and child health, tuberculosis, venereal diseases, nutrition and environmental sanitation.
Women's health is inextricably linked to their status in society. It benefits from equality, and suffers from discrimination. Today, the status and well-being of countless millions of women worldwide remain tragically low. As a result, human well-being in general suffers, and the prospects for future generations are dimmer. Global population ageing is resulting in the evolution towards societies which are, for the most part, female. Yet while women generally live longer than men, for many of them greater life expectancy carries no real advantage in terms of additional years lived free of disability.
In 1997, of a global total of 52.2 million deaths, 17.3 million were due to infectious and parasitic diseases; 15.3 million were due to circulatory diseases; 6.2 million were due to cancer; 2.9 million were due to respiratory diseases, mainly chronic obstructive pulmonary disease; and 3.6 million were due to perinatal conditions.
The first international classification edition, known as the International List of Causes of Death, was adopted by the International Statistical Institute in 1893. ICD is the foundation for the identification of health trends and statistics globally, and the international standard for reporting diseases and health conditions. It is the diagnostic classification standard for all clinical and research purposes.
A comprehensive system of quality assurance must be founded on a reliable system of licensing and independent analysis of the finished product, as well as upon assurance obtained through independent inspection that all manufacturing operations are carried out in conformity with accepted norms, referred to as "good manufacturing practices" (GMP)
Influenza A and B viruses are important human respiratory pathogens which are transmitted mainly by droplets and aerosols originating from the respiratory secretions of infected people, but occasionally also through contact with virus contaminated fomites.
BCG (Tuberculosis) Cholera Combined DT-Based Vaccines Dengue Diphtheria DNA vaccines Ebola Haemorrhagic fever with renal syndrome Haemophilus influenzae (Hib) Hepatitis A Hepatitis B Hepatitis E Human Papillomavirus (HPV) Influenza Japanese encephalitis (JE) Malaria Measles Meningococcal meningitis Mumps Pertussis Plant-derived vaccines…
The position paper is intended for use mainly by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media, and…